Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome

Abstract Background Homocysteine metabolism is altered in children with idiopathic nephrotic syndrome. Hyperhomocysteinemia is a risk factor of early atherosclerosis and glomerulosclerosis and may occur at time of first occurrence of idiopathic nephrotic syndrome. Methods Thirty children with first...

Full description

Bibliographic Details
Main Authors: Mohan Kundal, Abhijeet Saha, N.K. Dubey, Kanika Kapoor, Trayambak Basak, Gaurav Bhardwaj, Vinay Singh Tanwar, Shantanu Sengupta, Vinita Batra, Ashish Dutt Upadhayay, Ajay Bhatt
Format: Article
Language:English
Published: Wiley 2014-04-01
Series:Clinical and Translational Science
Subjects:
Online Access:https://doi.org/10.1111/cts.12145
id doaj-f11202583034401b8a61ead3bac7ae4d
record_format Article
spelling doaj-f11202583034401b8a61ead3bac7ae4d2020-11-25T02:37:06ZengWileyClinical and Translational Science1752-80541752-80622014-04-017213213610.1111/cts.12145Homocysteine Metabolism in Children with Idiopathic Nephrotic SyndromeMohan Kundal0Abhijeet Saha1N.K. Dubey2Kanika Kapoor3Trayambak Basak4Gaurav Bhardwaj5Vinay Singh Tanwar6Shantanu Sengupta7Vinita Batra8Ashish Dutt Upadhayay9Ajay Bhatt10Division of Pediatric Nephrology, Department of Pediatrics Postgraduate Institute of Medical Education and Research associated Dr. Ram Manohar Lohia Hospital New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaDepartment of Pathology GB Pant Hospital New Delhi IndiaDepartment of Biostatistics AIIMS New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaDepartment of Pathology GB Pant Hospital New Delhi IndiaDepartment of Biostatistics AIIMS New Delhi IndiaCSIR‐Institute of Genomics and Integrative Biology New Delhi IndiaAbstract Background Homocysteine metabolism is altered in children with idiopathic nephrotic syndrome. Hyperhomocysteinemia is a risk factor of early atherosclerosis and glomerulosclerosis and may occur at time of first occurrence of idiopathic nephrotic syndrome. Methods Thirty children with first episode of idiopathic nephrotic syndrome (FENS) aged 1–16 years along with 30 age‐ and sex‐matched healthy controls were enrolled in this study. Homocysteine and cysteine were measured with HPLC; vitamin B12 and folic acid were measured with electro‐chemilumiscence immunoassay. Primary outcome measure was plasma homocysteine level in children with FENS and in controls. Secondary outcome measures were (1) plasma and urine homocysteine and cysteine levels in children with FENS at 12 weeks and 1 year (remission) and (2) plasma and urine levels of vitamin B12 and folic acid in children with FENS, at 12 weeks and 1 year (remission). Results Plasma homocysteine and cysteine levels were comparable to controls in children with FENS, at 12 weeks and 1‐year remission. Plasma levels of vitamin B12 and folic acid were significantly decreased compared to controls in FENS due to increased urinary excretion, which normalize during remission at 12 weeks and 1 year. Urinary homocysteine and cysteine levels were significantly raised in FENS compared to controls and continued to be raised even at 12‐week and 1‐year remission. Conclusion Homocysteine metabolism is deranged in children with FENS. Renal effects of long‐term raised urinary homocysteine levels need to be studied.https://doi.org/10.1111/cts.12145homocysteinechildrennephrotic syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Mohan Kundal
Abhijeet Saha
N.K. Dubey
Kanika Kapoor
Trayambak Basak
Gaurav Bhardwaj
Vinay Singh Tanwar
Shantanu Sengupta
Vinita Batra
Ashish Dutt Upadhayay
Ajay Bhatt
spellingShingle Mohan Kundal
Abhijeet Saha
N.K. Dubey
Kanika Kapoor
Trayambak Basak
Gaurav Bhardwaj
Vinay Singh Tanwar
Shantanu Sengupta
Vinita Batra
Ashish Dutt Upadhayay
Ajay Bhatt
Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
Clinical and Translational Science
homocysteine
children
nephrotic syndrome
author_facet Mohan Kundal
Abhijeet Saha
N.K. Dubey
Kanika Kapoor
Trayambak Basak
Gaurav Bhardwaj
Vinay Singh Tanwar
Shantanu Sengupta
Vinita Batra
Ashish Dutt Upadhayay
Ajay Bhatt
author_sort Mohan Kundal
title Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
title_short Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
title_full Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
title_fullStr Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
title_full_unstemmed Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
title_sort homocysteine metabolism in children with idiopathic nephrotic syndrome
publisher Wiley
series Clinical and Translational Science
issn 1752-8054
1752-8062
publishDate 2014-04-01
description Abstract Background Homocysteine metabolism is altered in children with idiopathic nephrotic syndrome. Hyperhomocysteinemia is a risk factor of early atherosclerosis and glomerulosclerosis and may occur at time of first occurrence of idiopathic nephrotic syndrome. Methods Thirty children with first episode of idiopathic nephrotic syndrome (FENS) aged 1–16 years along with 30 age‐ and sex‐matched healthy controls were enrolled in this study. Homocysteine and cysteine were measured with HPLC; vitamin B12 and folic acid were measured with electro‐chemilumiscence immunoassay. Primary outcome measure was plasma homocysteine level in children with FENS and in controls. Secondary outcome measures were (1) plasma and urine homocysteine and cysteine levels in children with FENS at 12 weeks and 1 year (remission) and (2) plasma and urine levels of vitamin B12 and folic acid in children with FENS, at 12 weeks and 1 year (remission). Results Plasma homocysteine and cysteine levels were comparable to controls in children with FENS, at 12 weeks and 1‐year remission. Plasma levels of vitamin B12 and folic acid were significantly decreased compared to controls in FENS due to increased urinary excretion, which normalize during remission at 12 weeks and 1 year. Urinary homocysteine and cysteine levels were significantly raised in FENS compared to controls and continued to be raised even at 12‐week and 1‐year remission. Conclusion Homocysteine metabolism is deranged in children with FENS. Renal effects of long‐term raised urinary homocysteine levels need to be studied.
topic homocysteine
children
nephrotic syndrome
url https://doi.org/10.1111/cts.12145
work_keys_str_mv AT mohankundal homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT abhijeetsaha homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT nkdubey homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT kanikakapoor homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT trayambakbasak homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT gauravbhardwaj homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT vinaysinghtanwar homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT shantanusengupta homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT vinitabatra homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT ashishduttupadhayay homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
AT ajaybhatt homocysteinemetabolisminchildrenwithidiopathicnephroticsyndrome
_version_ 1724796694271361024